The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

D Dörfel, CJ Lechner, S Joas, T Funk… - Cancer Immunology …, 2018 - Springer
In chronic myeloid leukemia (CML), the translocation t (9; 22) results in the fusion protein
BCR-ABL (breakpoint cluster region-abelson murine leukemia), a tyrosine kinase mediating …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

D Dörfel, CJ Lechner, S Joas, T Funk… - Cancer Immunology …, 2018 - ncbi.nlm.nih.gov
In chronic myeloid leukemia (CML), the translocation t (9; 22) results in the fusion protein
BCR-ABL (breakpoint cluster region-abelson murine leukemia), a tyrosine kinase mediating …

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.

D Dörfel, CJ Lechner, S Joas, T Funk… - Cancer Immunology …, 2018 - search.ebscohost.com
In chronic myeloid leukemia (CML), the translocation t (9; 22) results in the fusion protein
BCR-ABL (breakpoint cluster region-abelson murine leukemia), a tyrosine kinase mediating …

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

D Dörfel, CJ Lechner, S Joas, T Funk… - Cancer Immunology …, 2018 - search.proquest.com
In chronic myeloid leukemia (CML), the translocation t (9; 22) results in the fusion protein
BCR-ABL (breakpoint cluster region-abelson murine leukemia), a tyrosine kinase mediating …

[引用][C] The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

D Doerfel, CJ Lechner, S Joas, T Funk… - Cancer Immunology …, 2018 - ub01.uni-tuebingen.de
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human
dendritic cells The BCR-ABL inhibitor nilotinib influences phenotype and function of …

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

D Dörfel, CJ Lechner, S Joas, T Funk… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
In chronic myeloid leukemia (CML), the translocation t (9; 22) results in the fusion protein
BCR-ABL (breakpoint cluster region-abelson murine leukemia), a tyrosine kinase mediating …

[引用][C] The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

D Doerfel, CJ Lechner, S Joas, T Funk, M Gutknecht… - 2018 - oparu.uni-ulm.de

[引用][C] The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells

D Doerfel, CJ Lechner, S Joas… - Cancer …, 2018 - tobias-lib.ub.uni-tuebingen.de
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human
dendritic cells The BCR-ABL inhibitor nilotinib influences phenotype and function of …

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.

D Dörfel, CJ Lechner, S Joas, T Funk… - Cancer Immunology …, 2018 - europepmc.org
In chronic myeloid leukemia (CML), the translocation t (9; 22) results in the fusion protein
BCR-ABL (breakpoint cluster region-abelson murine leukemia), a tyrosine kinase mediating …

The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells.

D Dörfel, CJ Lechner, S Joas, T Funk… - Cancer Immunology …, 2018 - europepmc.org
In chronic myeloid leukemia (CML), the translocation t (9; 22) results in the fusion protein
BCR-ABL (breakpoint cluster region-abelson murine leukemia), a tyrosine kinase mediating …